FilingPulse

NGM insider transaction filings

NGM BIOPHARMACEUTICALS INC — 14 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2024-04-08. Screen NGM transaction legs live →

Insider transaction summary — last 90 days

No Form 4 filings for NGM between 2026-06-13 and 2026-09-11. The table below lists the most recent filings on record.

Recent Form 4 filings — NGM BIOPHARMACEUTICALS INC

FiledFormInsiderReported transactionsSource
2024-04-084Viret Jean-Frederic — Chief Financial OfficerCode (U): 3,038 · Disposition to issuer (D): 450,000 (derivative)EDGAR
2024-04-084WOODHOUSE DAVID J — Chief Executive Officer, DirectorCode (U): 23,993 · Code (U): 97,654 · Disposition to issuer (D): 95,400 (derivative) · Disposition to issuer (D): 255,000 (derivative) · Disposition to issuer (D): 87,013 (derivative) · Disposition to issuer (D): 57,833 (derivative) · +7 moreEDGAR
2024-04-084Perlich Irene — Principal Accounting OfficerCode (U): 6,284 · Disposition to issuer (D): 7,500 (derivative) · Disposition to issuer (D): 50,000 (derivative) · Disposition to issuer (D): 35,000 (derivative) · Disposition to issuer (D): 17,500 (derivative) · Disposition to issuer (D): 30,000 (derivative) · +1 moreEDGAR
2024-04-084Ho Carole — DirectorDisposition to issuer (D): 78,407 (derivative) · Disposition to issuer (D): 24,222 (derivative) · Disposition to issuer (D): 19,619 (derivative) · Disposition to issuer (D): 39,515 (derivative)EDGAR
2024-04-084Guyer Shelly D — DirectorDisposition to issuer (D): 78,407 (derivative) · Disposition to issuer (D): 24,222 (derivative) · Disposition to issuer (D): 19,619 (derivative) · Disposition to issuer (D): 16,806 (derivative) · Disposition to issuer (D): 49,197 (derivative)EDGAR
2024-04-084Hooper Suzanne Sawochka — DirectorCode (U): 7,000 · Disposition to issuer (D): 78,407 (derivative) · Disposition to issuer (D): 24,222 (derivative) · Disposition to issuer (D): 19,619 (derivative) · Disposition to issuer (D): 16,806 (derivative) · Disposition to issuer (D): 38,000 (derivative) · +2 moreEDGAR
2024-04-084Lieu Hsiao D — Chief Medical OfficerCode (U): 19,349 · Disposition to issuer (D): 39,750 (derivative) · Disposition to issuer (D): 190,000 (derivative) · Disposition to issuer (D): 25,000 (derivative) · Disposition to issuer (D): 100,000 (derivative) · Disposition to issuer (D): 150,000 (derivative) · +2 moreEDGAR
2024-04-084TCG Opportunity III GP, LLC — 10% ownerDisposition to issuer (D): 949,862 · Disposition to issuer (D): 2,650,177 · Disposition to issuer (D): 90,442 · Disposition to issuer (D): 11,103,333 · Disposition to issuer (D): 858,035 · Disposition to issuer (D): 968,990 · +8 moreEDGAR
2024-04-084COLUMN GROUP GP, LP — 10% owner
COLUMN GROUP III, LP — 10% owner
COLUMN GROUP III-A, LP — 10% owner
COLUMN GROUP III GP, LP — 10% owner
Column Group IV, LP — 10% owner
Column Group IV-A, LP — 10% owner
Column Group IV GP, LP — 10% owner
TCG IV GP, LLC — 10% owner
Column Group Opportunity III, LP — 10% owner
Column Group Opportunity III GP, LP — 10% owner		Disposition to issuer (D): 949,862 · Disposition to issuer (D): 2,650,177 · Disposition to issuer (D): 90,442 · Disposition to issuer (D): 11,103,333 · Disposition to issuer (D): 858,035 · Disposition to issuer (D): 968,990 · +8 moreEDGAR
2024-04-084Pierce Valerie L — See RemarksCode (U): 26,458 · Disposition to issuer (D): 36,750 (derivative) · Disposition to issuer (D): 200,000 (derivative) · Disposition to issuer (D): 100,000 (derivative) · Disposition to issuer (D): 150,000 (derivative) · Disposition to issuer (D): 150,000 (derivative) · +1 moreEDGAR
2024-04-084COLUMN GROUP L P — Director, 10% owner
Svennilson Peter — 10% owner
Kutzkey Tim — 10% owner
Ponoi Capital II, LP — 10% owner
Ponoi II Management, LLC — 10% owner
PONOI CAPITAL, LP — 10% owner
Ponoi Management, LLC — 10% owner
COLUMN GROUP II, LP — 10% owner
Column Group Management LP — 10% owner
Column Group II GP, LP — 10% owner		Disposition to issuer (D): 949,862 · Disposition to issuer (D): 2,650,177 · Disposition to issuer (D): 90,442 · Disposition to issuer (D): 11,103,333 · Disposition to issuer (D): 858,035 · Disposition to issuer (D): 968,990 · +8 moreEDGAR
2024-04-084PERLMUTTER ROGER M — DirectorDisposition to issuer (D): 78,407 (derivative) · Disposition to issuer (D): 24,222 (derivative) · Disposition to issuer (D): 46,238 (derivative)EDGAR
2024-04-084RIEFLIN WILLIAM JL — DirectorCode (U): 5,172 · Code (U): 2,769,168 · Disposition to issuer (D): 78,407 (derivative) · Disposition to issuer (D): 80,000 (derivative) · Disposition to issuer (D): 80,000 (derivative) · Disposition to issuer (D): 75,000 (derivative) · +2 moreEDGAR
2024-04-084GOEDDEL DAVID V — Director, 10% ownerDisposition to issuer (D): 134,180 · Disposition to issuer (D): 190,000 · Disposition to issuer (D): 949,862 · Disposition to issuer (D): 2,650,177 · Disposition to issuer (D): 90,442 · Disposition to issuer (D): 11,103,333 · +13 moreEDGAR

Recent 8-K events — NGM BIOPHARMACEUTICALS INC

FiledFormItems reportedSource
2024-04-058-K1.02 — Termination of a Material Definitive Agreement
2.01 — Completion of Acquisition or Disposition of Assets
3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
3.03 — Material Modification to Rights of Security Holders
5.01 — Changes in Control of Registrant
5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
8.01 — Other Events
9.01 — Financial Statements and Exhibits		EDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=NGM returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →